Correlation Between Eli Lilly and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eli Lilly and and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Eli Lilly and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Takeda Pharmaceutical.

Diversification Opportunities for Eli Lilly and Takeda Pharmaceutical

0.61

Correlation Coefficient

Eli Lilly  Takeda Pharmaceutical

Poor diversification

The 3 months correlation between Eli and Takeda is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Eli Lilly i.e., Eli Lilly and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Eli Lilly and Takeda Pharmaceutical

Considering the 90-day investment horizon Eli Lilly is expected to generate 1.87 times less return on investment than Takeda Pharmaceutical. In addition to that, Eli Lilly is 1.77 times more volatile than Takeda Pharmaceutical Co. It trades about 0.06 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.18 per unit of volatility. If you would invest  1,327  in Takeda Pharmaceutical Co on December 27, 2024 and sell it today you would earn a total of  175.00  from holding Takeda Pharmaceutical Co or generate 13.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Eli Lilly and  vs.  Takeda Pharmaceutical Co

Eli Lilly

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Eli Lilly may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Takeda Pharmaceutical

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Takeda Pharmaceutical disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eli Lilly and Takeda Pharmaceutical

The main advantage of trading using opposite Eli Lilly and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Eli Lilly and and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.